Skip to content

Study · Non-randomized trial · n = 40 · 2008

4 results

Effects of cerebrolysin on moderate cognitive impairments in cerebral vascular insufficiency (a clinical-electrophysiological study).

Damulin IV, Koberskaya NN, Mkhitaryan EA

Neuroscience and behavioral physiology1 Jul 2008Cited by 7 (Europe PMC)

PMID18607744 (opens in a new tab)DOI10.1007/s11055-008-9014-5 (opens in a new tab)PepBankPUB-18607744
Publisher pagePubMedAsk about this study
Jump to 4 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study4

4 results from studies that gave the peptide. 4 results from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In patients with cerebral vascular insufficiency, Cerebrolysin decreased memory impairment severity, with delayed effects after treatment.

    In plain wordsIn patients with cerebral vascular insufficiency, Cerebrolysin reduced memory problems, with delayed effects after treatment.

    Peptide
    Cerebrolysin
    Outcome
    DecreaseMemory impairment severity
    Study

    n = 40

    Outcome group
    Cognition and memory · Nervous system and cognition
    Studied dose
    10 ml · i.v. infusions · 20 daily infusionsAs given in this study (human).

    Source sentences

    Summary
    Courses of cerebrolysin treatment decreased the severity of memory and attention impairments, improving the overall cognitive status of the patients.
    2 context sentences
    Summary · context
    The effects of treatment at the doses used here were delayed and were seen three months after completion of treatment.
    Summary · context
    The efficacy of treatment with cerebrolysin was studied in 40 patients with cerebral vascular insufficiency. Cerebrolysin (20 daily i.v. infusions of 10 ml in 200 ml of physiological saline) was found to be an effective means of treating this group of patients.
  2. 02HumanNon-randomized trialEfficacy outcome

    In patients with cerebral vascular insufficiency, Cerebrolysin decreased attention impairment severity, with delayed effects after treatment.

    In plain wordsIn patients with cerebral vascular insufficiency, Cerebrolysin reduced attention problems, with delayed effects after treatment.

    Peptide
    Cerebrolysin
    Outcome
    DecreaseAttention impairment severity
    Study

    n = 40

    Outcome group
    Cognition and memory · Nervous system and cognition
    Studied dose
    10 ml · i.v. infusions · 20 daily infusionsAs given in this study (human).

    Source sentences

    Summary
    Courses of cerebrolysin treatment decreased the severity of memory and attention impairments, improving the overall cognitive status of the patients.
    2 context sentences
    Summary · context
    The effects of treatment at the doses used here were delayed and were seen three months after completion of treatment.
    Summary · context
    The efficacy of treatment with cerebrolysin was studied in 40 patients with cerebral vascular insufficiency. Cerebrolysin (20 daily i.v. infusions of 10 ml in 200 ml of physiological saline) was found to be an effective means of treating this group of patients.
  3. 03HumanNon-randomized trialEfficacy outcome

    In patients with cerebral vascular insufficiency, Cerebrolysin improved overall cognitive status, with delayed effects after treatment.

    In plain wordsIn patients with cerebral vascular insufficiency, Cerebrolysin improved overall cognitive status, with delayed effects after treatment.

    Peptide
    Cerebrolysin
    Outcome
    IncreaseOverall cognitive status
    Study

    n = 40

    Outcome group
    Cognition and memory · Nervous system and cognition
    Studied dose
    10 ml · i.v. infusions · 20 daily infusionsAs given in this study (human).

    Source sentences

    Summary
    Courses of cerebrolysin treatment decreased the severity of memory and attention impairments, improving the overall cognitive status of the patients.
    2 context sentences
    Summary · context
    The effects of treatment at the doses used here were delayed and were seen three months after completion of treatment.
    Summary · context
    The efficacy of treatment with cerebrolysin was studied in 40 patients with cerebral vascular insufficiency. Cerebrolysin (20 daily i.v. infusions of 10 ml in 200 ml of physiological saline) was found to be an effective means of treating this group of patients.
  4. 04HumanNon-randomized trialEfficacy outcome

    In patients with cerebral vascular insufficiency, P300 electrophysiological results supported the clinical and cognitive findings during Cerebrolysin treatment.

    In plain wordsIn patients with cerebral vascular insufficiency, brain electrical tests supported the clinical and cognitive findings during Cerebrolysin treatment.

    Peptide
    Cerebrolysin
    Outcome
    Direction not reportedP300 cognitive evoked potential
    Study

    n = 40

    Outcome group
    Cognition and memory · Nervous system and cognition
    Studied dose
    10 ml · i.v. infusions · 20 daily infusionsAs given in this study (human).

    Source sentences

    Summary
    Clinical observations and neuropsychological testing were supported by electrophysiological results, in terms of the P300 cognitive evoked potential.
    1 context sentence
    Summary · context
    The efficacy of treatment with cerebrolysin was studied in 40 patients with cerebral vascular insufficiency. Cerebrolysin (20 daily i.v. infusions of 10 ml in 200 ml of physiological saline) was found to be an effective means of treating this group of patients.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.